000 01345 a2200373 4500
005 20250511224130.0
264 0 _c19901115
008 199011s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.98.4.835
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarpel, J P
245 0 0 _aA comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.
_h[electronic resource]
260 _bChest
_cOct 1990
300 _a835-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aCarbon Dioxide
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aForced Expiratory Volume
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aIpratropium
_xtherapeutic use
650 0 4 _aLung Diseases, Obstructive
_xblood
650 0 4 _aMetaproterenol
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aOxygen
_xblood
650 0 4 _aVital Capacity
_xdrug effects
700 1 _aPesin, J
700 1 _aGreenberg, D
700 1 _aGentry, E
773 0 _tChest
_gvol. 98
_gno. 4
_gp. 835-9
856 4 0 _uhttps://doi.org/10.1378/chest.98.4.835
_zAvailable from publisher's website
999 _c2151282
_d2151282